EGFR T790M (DBCOND0025017)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05377788	Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer	Lazertinib	Not Available	Not Available	unknown_status
NCT03810066	Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)	Osimertinib	treatment	2	completed
NCT06573073	Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation	No drug interventions	Not Available	Not Available	recruiting
NCT04862780	(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC	Osimertinib Tigozertinib	treatment	1 / 2	active_not_recruiting
NCT05701384	Lazertinib 160mg in EGFR T790M NSCLC	Lazertinib	treatment	2	not_yet_recruiting
NCT03532698	Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)	Acetylsalicylic acid Osimertinib	Not Available	Not Available	unknown_status
NCT03543683	Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC	Acetylsalicylic acid Osimertinib	Not Available	Not Available	unknown_status
NCT03861156	D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer	Befotertinib	treatment	2	completed
NCT05458726	Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC	Carboplatin Osimertinib Paclitaxel Pemetrexed	diagnostic	2	unknown_status
NCT04592666	Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer	Almonertinib Carboplatin Pemetrexed	treatment	2	unknown_status